SUBSCRIBE TO GET OUR FREE ALERTS TODAY
- Don't Trade RLFTF until you read a Full Report!
- Get Alert's on companies like RLFTF BEFORE the Rest.
- Is RLFTF a Buy? Receive Exclusive Research and Analysis.
- Find out what RLFTF Insiders don't want you to know.
RLFTF Stock News
- Relief Therapeutics has Published its Annual Report 04/30/2024 05:20 AMGENEVA, SWITZARLAND / ACCESSWIRE / April 30, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, ...
- RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting 04/26/2024 03:45 PMShareholders approved all proposals by a large majority GENEVA, SWITZERLAND / ACCESSWIRE / April 26, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF) (OTCQB:RLFTF, RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed ...
- RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting 03/27/2024 06:20 AMRelief Therapeutics Calls Extraordinary General MeetingAnticipated Board of Directors Overhaul GENEVA, SWITZERLAND / ACCESSWIRE / March 27, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), ...
- Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE 03/22/2024 06:20 AMGENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, ...
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria 03/22/2024 06:00 AMPKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024 earningsEstimated peak sales of more than $10 million annuallyU.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company foc
Join the Stock Event that’s Sweeping Wall Street!
We’re Not your “Everyday” Stock Newsletter
In a world where Newsletters churn out pick after pick everyday, with little or no research that are usually more “miss” than hit, StockoftheWeek.com has come to break the cycle and end the madness!
ONE BIG PICK. ONCE A WEEK
We don’t overburden our members with junk. We take our time to research, analyze, and do our due diligence. Every profile, both compensated & uncompensated, must meet our strict criteria. Our goal is to provide members with One Big Profile per week. Each week’s new profile is a highly anticipated, CAN’T-MISS EVENT. And for good reason…
IMPECCABLE TRACK RECORD
“It takes 20 years to build a reputation and five minutes to ruin it. If you think about that you’ll do things differently.” Legendary Investor, Warren Buffett
Our track record is our reputation. And you can be sure we don’t take it lightly. That’s why we strive to be the Top Financial Newsletter on the Street Today. Subscribe today!
How it Works
Enter your email & subscribe to our
Stock Alert Newsletter
Receive our Stock Alerts to
Your Inbox or via Text Message
Follow us on Twitter for updates &
Play-by-play
Open your platform &
